0.05HKD
45.62 MHKD
1.07 BHKD
813.44 M
About KINDSTAR GLOBALGENE TECHNOLOGY INC
Sector
Industry
CEO
Shi Ang Huang
Website
Headquarters
Wuhan
Founded
2007
ISIN
KYG5262E1044
FIGI
BBG00ZF3HWC7
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. It operates through the following segments: Hematology Testing, Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, COVID-19 Related Testing, Routine Testing, and Others. The Others segment includes testing services for research and development projects, and others and miscellaneous services. The company was founded on August 24, 2007 and is headquartered in Wuhan, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 9960 is 1.51 HKD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange KINDSTAR GLOBALGENE TECHNOLOGY INC stocks are traded under the ticker 9960.
KINDSTAR GLOBALGENE TECHNOLOGY INC is going to release the next earnings report on Aug 14, 2024. Keep track of upcoming events with our Earnings Calendar.
9960 earnings for the last quarter are 0.02 HKD whereas the estimation was 0.05 HKD which accounts for −50.00% surprise. Estimated earnings for the next quarter are 0.03 HKD. See more details about KINDSTAR GLOBALGENE TECHNOLOGY INC earnings.
KINDSTAR GLOBALGENE TECHNOLOGY INC revenue for the last quarter amounts to 823.10 M HKD despite the estimated figure of 578.01 M HKD. In the next quarter revenue is expected to reach 570.91 M HKD.
Yes, you can track KINDSTAR GLOBALGENE TECHNOLOGY INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, 9960 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KINDSTAR GLOBALGENE TECHNOLOGY INC stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KINDSTAR GLOBALGENE TECHNOLOGY INC EBITDA is 7.43 M HKD, and current EBITDA margin is 0.77%. See more stats in KINDSTAR GLOBALGENE TECHNOLOGY INC financial statements.